Managers / Q1 2020 · view latest →
DSC Advisors, L.P.
CIK 0001299434 · 900 NORTH MICHIGAN AVENUE, SUITE 1600, CHICAGO, IL, 60611 · (312) 915-2485
Summary
Dsc Advisors, L.P. reported $102M in U.S.-listed holdings across 35 positions for Q1 2020.
Its largest position, GOOG, represents 12.2% of the portfolio.
Compared with Q4 2019, the fund opened 3 new positions and exited 57.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 66.6% · $68M
- ETP · 25.2% · $26M
- Other · 8.2% · $8M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SPYSPDR S&P 500 ETF TR | NEW | +100.0K | 100.0K | +$26M | $26M |
| HCAHCA HEALTHCARE INC | NEW | +172.2K | 172.2K | +$15M | $15M |
| MENLO THERAPEUTICS INC | NEW | +2.08M | 2.08M | +$6M | $6M |
| ZBHZIMMER BIOMET HLDGS INC | SOLD OUT | −78.4K | 0 | −$12M | $0 |
| DALDELTA AIR LINES INC DEL | SOLD OUT | −200.0K | 0 | −$12M | $0 |
| CORAMERISOURCEBERGEN CORP | SOLD OUT | −134.0K | 0 | −$11M | $0 |
| FOAMIX PHARMACEUTICALS LTD | SOLD OUT | −3.37M | 0 | −$11M | $0 |
| DVADAVITA INC | SOLD OUT | −130.0K | 0 | −$10M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2020
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | GOOGALPHABET INC | CAP STK CL C · CAP STK CL A | 12.25% | $13M | 10.8K |
| 2 | ATHENE HLDG LTD | CL A | 8.07% | $8M | 333.0K |
| 3 | MSMORGAN STANLEYhistory → | COM NEW | 8.05% | $8M | 242.3K |
| 4 | CVSCVS HEALTH CORPhistory → | COM | 7.65% | $8M | 132.0K |
| 5 | HCAHCA HEALTHCARE INChistory → | COM | 7.56% | $8M | 86.2K |
| 6 | MENLO THERAPEUTICS INC | COM | 5.43% | $6M | 2.08M |
| 7 | ACELACCEL ENTERTAINMENT INC | COM CL A1 · *W EXP 11/20/202 | 4.10% | $4M | 647.1K |
| 8 | ALXNALEXION PHARMACEUTICALS INChistory → | COM | 3.95% | $4M | 45.0K |
| 9 | BMYBRISTOL-MYERS SQUIBB COhistory → | COM | 2.74% | $3M | 50.3K |
| 10 | KEMPHARM INC | COM | 0.90% | $922,000 | 4.10M |
| 11 | MSFTMICROSOFT CORP | COM | 0.62% | $635,000 | 4.0K |
| 12 | NFLXNETFLIX INC | COM | 0.50% | $516,000 | 1.4K |
| 13 | METAFACEBOOK INC | CL A | 0.50% | $508,000 | 3.0K |
| 14 | VVISA INC | COM CL A | 0.47% | $483,000 | 3.0K |
| 15 | ADBEADOBE INC | COM | 0.46% | $470,000 | 1.5K |
| 16 | MAMASTERCARD INC | CL A | 0.43% | $445,000 | 1.8K |
| 17 | CRMSALESFORCE COM INC | COM | 0.42% | $426,000 | 3.0K |
| 18 | ACNACCENTURE PLC IRELAND | SHS CLASS A | 0.41% | $420,000 | 2.6K |
| 19 | PYPLPAYPAL HLDGS INC | COM | 0.39% | $401,000 | 4.2K |
| 20 | ORCLORACLE CORP | COM | 0.38% | $394,000 | 8.2K |
| 21 | IBMINTERNATIONAL BUSINESS MACHS | COM | 0.37% | $376,000 | 3.4K |
| 22 | AAPLAPPLE INC | COM | 0.34% | $353,000 | 1.4K |
| 23 | ADPAUTOMATIC DATA PROCESSING IN | COM | 0.22% | $227,000 | 1.7K |
| 24 | AMZNAMAZON COM INC | COM | 0.21% | $211,000 | 108 |
| 25 | INTUINTUIT | COM | 0.20% | $208,000 | 905 |
| 26 | SPYSPDR S&P 500 ETF TR | TR UNIT | 0.01% | $11,000 | 43 |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2024 | $11M | 19 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $30M | 24 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $63M | 34 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $61M | 32 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $78M | 33 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $67M | 31 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $115M | 24 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $44M | 17 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $97M | 97 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $100M | 113 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $290M | 132 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $129M | 72 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $98M | 74 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $138M | 74 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $161M | 85 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $121M | 51 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $149M | 49 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $91M | 37 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $102M | 35 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $209M | 88 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $506M | 97 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $569M | 85 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $544M | 81 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 1 additional manager.
- DSCQG PR LLC028-18129
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.